Starting April 1st, 2020 through July 1st, 2020, IMNA is offering free access to the TrialME platform for all teams researching COVID-19 and other life debilitating diseases.
TrialME offers sites a seamless shift to a hybrid structure that follows the FDA’s new guidelines during COVID-19 pandemic; the platform monitors, engages, and communicates with patients from the comfort and safety of their home. Continue reading